Doyoung Yoon
Overview
Explore the profile of Doyoung Yoon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chun J, Yoon D, Nowakowska A, Lee H, Lee C, Kim J, et al.
Vaccine
. 2024 Sep;
42(26):126355.
PMID: 39260058
Although the coronavirus pandemic has ended, new variants of concern (VOCs) continue to emerge. Therefore, novel vaccines targeting VOCs are highly warranted. We initially constructed three recombinant baculovirus-vectored vaccines (AcHERV-COVID19S)...
2.
Lee C, Kim M, Chun J, Kim S, Yoon D, Lee H, et al.
Vaccines (Basel)
. 2024 Mar;
12(3).
PMID: 38543967
Varicella-zoster virus (VZV) poses lifelong risks, causing varicella and herpes zoster (HZ, shingles). Currently, varicella and HZ vaccines are predominantly live attenuated vaccines or adjuvanted subunit vaccines utilizing VZV glycoprotein...
3.
Lee H, Chun J, Kim S, Aleksandra N, Lee C, Yoon D, et al.
J Microbiol Biotechnol
. 2023 Oct;
34(1):185-191.
PMID: 37830223
Various types of vaccines have been developed against COVID-19, including vector vaccines. Among the COVID-19 vaccines, AstraZeneca's chimpanzee adenoviral vaccine was the first to be commercialized. For viral vector vaccines,...
4.
Choi J, Bae S, Hong J, Ryoo S, Jhun H, Hong K, et al.
Proc Natl Acad Sci U S A
. 2010 Nov;
107(49):21082-6.
PMID: 21078994
Inflammatory cytokines mediate inflammatory bowel diseases (IBDs) and cytokine blocking therapies often ameliorate the disease severity. IL-32 affects inflammation by increasing the production of IL-1, TNFα, and several chemokines. Here,...
5.
Jaekal J, Jhun H, Hong J, Park S, Lee J, Yoon D, et al.
Vet Immunol Immunopathol
. 2010 Jun;
137(1-2):166-71.
PMID: 20537728
Interleukin-32 (IL-32) is a new cytokine produced mainly by T-cells, natural killer cells, and epithelial cells after stimulation with IL-2, IL-12 plus IL-18, and IFNgamma, respectively. IL-32 induces various proinflammatory...
6.
Hong J, Bae S, Kang Y, Yoon D, Bai X, Chan E, et al.
Cytokine
. 2009 Nov;
49(2):171-6.
PMID: 19880327
Targeting major proinflammatory cytokines such as IL-1beta and TNFalpha is of great interest in patients with chronic inflammatory diseases, including rheumatoid arthritis, colitis, and psoriasis. The cytokine Interleukin (IL)-32 induces...
7.
Kim S, Lee S, Her E, Bae S, Choi J, Hong J, et al.
BMB Rep
. 2008 Nov;
41(11):814-9.
PMID: 19017495
Interleukin-32 (IL-32) induces a variety of proinflammatory cytokines and chemokines. The IL-32 transcript was reported originally in activated T cells; subsequently, it was demonstrated to be abundantly expressed in epithelial...
8.
Park H, Kim J, Lee J, Cho B, Lee W, Kim T, et al.
Immunol Lett
. 2004 Aug;
95(1):57-61.
PMID: 15325798
Interleukin-18 (IL-18) is an 18-kDa cytokine produced by lipopolysaccharide (LPS)-activated macrophages or Kupffer cells. In addition, IL-18 is also produced by many different types of cells and tissues, including epidermal...